指南与共识主动脉疾病

支持血管外科学会遗传性主动脉病管理指南的系统综述

A systematic review supporting the Society for Vascular Surgery guidelines on the management of heritable aortopathies.
指南 / 共识 · J Vasc Surg · 2023-06-15

为支持血管外科学会制定遗传性主动脉病与动脉病管理临床实践指南,本文系统综述了12项研究,评估六个临床问题。证据显示遗传性主动脉病患者B型主动脉夹层TEVAR后生存率高但随访有限,无危险因素患者基因检测阳性率36%且与15年内新发主动脉事件相关,所有结局证据确定性极低。

要点

  • 遗传性主动脉病患者B型主动脉夹层TEVAR后短期生存率高,但长期随访数据有限。
  • 无遗传性主动脉病危险因素的主动脉瘤/夹层患者基因检测阳性率36%,与15年内新发主动脉事件相关。
  • Black患者30天死亡率低于White患者但主动脉再干预率更高,所有结局证据确定性极低。

核心结论

  • 现有证据提示遗传性主动脉病年轻患者B型主动脉夹层TEVAR后生存率高,但长期随访有限。
  • 急性主动脉瘤和夹层患者基因检测阳性率高:有遗传性主动脉病危险因素者多数阳性,其他患者超过三分之一阳性,且与15年内新发主动脉事件相关。

研究设计与样本

  • 血管外科学会写作委员会委托的系统综述,检索多个数据库,针对指南委员会确定的六个评估与管理问题。
  • 纳入12项研究,由独立评审员配对筛选和评价。

主要发现

  • 未检索到遗传性主动脉病患者主动脉瘤腔内修复长期结局的研究,也未检索到有主动脉夹层或动脉瘤病史孕妇新发主动脉事件的研究。
  • 小病例系列显示B型主动脉夹层内移植物修复后15个月(范围7-28个月)生存率100%、无主动脉干预生存率100%。
  • 无遗传性主动脉病危险因素的主动脉瘤和夹层患者中36%发现阳性遗传学诊断,这些患者中位随访5个月时死亡率为11%。
  • Black患者30天死亡率低于White患者(5.6% vs 9.0%),但主动脉夹层修复后30天总体主动脉再干预率更高(47% vs 27%)。
  • Black患者因动脉瘤扩张和内漏在30天时行主动脉再干预的比例高于White患者。

关键数值与推荐

  • 所有评估结局的证据确定性均判定为极低。
  • Black患者30天死亡率5.6% vs White患者9.0%。
  • Black患者主动脉夹层修复后30天总体主动脉再干预率47% vs White患者27%。
  • 无危险因素患者基因检测阳性率36%,中位随访5个月死亡率11%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未检索到遗传性主动脉病患者主动脉瘤腔内修复长期结局的研究。
  • 未检索到有主动脉夹层或动脉瘤病史孕妇新发主动脉事件的研究。
  • B型主动脉夹层内移植物修复后随访有限,仅至15个月(范围7-28个月)。
  • 所有评估结局的证据确定性均判定为极低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To support the development of clinical practice guidelines on the management of patients with genetic aortopathies and arteriopathies, a writing committee from the Society for Vascular Surgery has commissioned this systematic review. METHODS: We conducted a systematic review and searched multiple databases for studies addressing six questions identified by the Society for Vascular Surgery guideline committee about evaluating and managing patients with genetic aortopathies and arteriopathies. Studies were selected and appraised by pairs of independent reviewers. RESULTS: We included 12 studies in this systematic review. We did not identify studies about the long-term outcomes of endovascular repair for aortic aneurysm in patients with heritable aortopathy or about new aortic events in pregnant women with a history of aortic dissection (AD) or aneurysm. A small case series demonstrated a 100% survival rate and 100% aortic intervention-free survival at 15 months (range, 7-28 months) after endograft repair for type B AD. A positive genetic diagnosis was discovered in 36% of patients with aortic aneurysms and dissections who had no risk factors for hereditary aortopathies, and these patients had a mortality rate of 11% at a median follow-up duration of 5 months. Black patients had lower 30-day mortality than White patients (5.6% vs 9.0%, respectively), but they had a higher overall aortic reintervention rate at 30 days after AD repair (47% vs 27%, respectively). Aortic reinterventions owing to aneurysmal expansion and endoleak at 30 days were higher in Black patients than White patients. The certainty of evidence was judged to be very low across all the outcomes evaluated in this systematic review. CONCLUSIONS: The available evidence suggests high survival after thoracic endovascular aortic repair for type B AD in young patients with heritable aortopathies, but with limited long-term follow-up. Genetic testing in patients with acute aortic aneurysms and dissections had a high yield. It was positive for most patients with risk factors for hereditary aortopathies and in more than one-third for all other patients, and was associated with new aortic events within 15 years.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Firwana M, Hasan B, Saadi S, et al. A systematic review supporting the Society for Vascular Surgery guidelines on the management of heritable aortopathies. J Vasc Surg. 2023. PMID: 37327953. doi:10.1016/j.jvs.2023.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。